Oxidized apoA-I determination by mass spectrometry

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S086000

Reexamination Certificate

active

07972794

ABSTRACT:
Methods are provided for the detection and quantitation of proteins generally and apolipoprotein A-I and oxidized derivatives thereof in particular. Further provided are methods for the assessment of the risk cardiovascular disease in a subject, wherein the assessment is based on the amount of oxidized and unoxidized apolipoprotein A-I in a biological sample obtained from a subject.

REFERENCES:
patent: 5756291 (1998-05-01), Griffin et al.
patent: 6107623 (2000-08-01), Bateman et al.
patent: 6124137 (2000-09-01), Hutchens et al.
patent: 6204500 (2001-03-01), Whitehouse et al.
patent: 6268144 (2001-07-01), Koster
patent: 6309888 (2001-10-01), Holvoet et al.
patent: 2003/0113728 (2003-06-01), Salonen
patent: 2005/0239136 (2005-10-01), Hazen et al.
patent: 2006/0172429 (2006-08-01), Nilsson et al.
patent: 2007/0099242 (2007-05-01), Heinecke et al.
Brennan et al., “Prognostic Value of Myeloperoxidase in Patients with Chest Pain”, The New England Journal of Medicine, 349(17):1595-1604, 2003.
Chisolm et al., “The Oxidative Modification Hypothesis of Atherogenesis: An Overview”, Free Radical Biology & Medicine, 28:1815-1826, 2000.
Heinecke et al., “Oxidative Stress: New Approaches to Diagnosis and Prognosis in Atherosclerosis”, American Journal of Cardiology, 91:12A-16A, 2003.
Merchant et al., “Recent Advancements in Surface-Enhanced Laser Desorption/Ionization-time of Flight-Mass Spectrometry”, Electrophoresis, 21:1164-67, 2000.
Navab et al., “Oxidized Lipids as Mediators of Coronary Heart Disease”, Curr. Opin. Lipidol., 13:363-372, 2002.
Olsen et al.,“Trypsin Cleaves Exclusively C-Terminal to Arginine and Lysine Residues”, Molecular & Cellular Proteomics, 3:608-614, 2004.
Ross et al., “Atherosclerosis—An Inflammatory Disease”, New England Journal of Medicine, 340:115-126, 2003.
Wright et al., “Proteinchip Surface Enhanced Laser Desorption/Ionization (SELDI) Mass Spectrometry: A Novel Protein Biochip Technology for Detection of Prostate Cancer Biomarkers in Complex Protein Mixtures”, Prostate Cancer and Prostatic Diseases, 2:264-76, 1999.
Zheng et al., “Apolipoprotein A-I is a Selective Target for Myeloperoxidase-Catalyzed Oxidation and Functional Impairment in Subjects with Cardiovascular Disease”, The Journal of Clinical Investigation, 114:259-541, 2004.
Zheng et al., “Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages”, The Journal of Biological Chemistry, 280:38-47, 2005.
International Search Report for PCT Patent Application No. PCT/US2007/73607.
Garner et al., Oxidation of high density lipoproteins. Journal of Biological Chemistry, 273(11): p. 6080-6087, 1998.
Bartolucci et al., Liquid chromatography tandem mass spectrometric quantitation of sulfamethazine and its metabolites: direct analysis of swine urine by triple quadrupole and by ion trap mass spectrometry. Rapid Communications in Mass Spectrometry, 14: 967-973, 2000.
Barr et al., Isotope dilution-mass spectrometric quantification of speific proteins: model application with apolipoprotein A-I, Clinical Chemistry 42:10, pp. 1676-1682 (1996).
Bergt et al, Tyrosine Chlorination in Apo A-I is Directed by Lysine Residues When Hypochlorous Acid Oxidizes HDL, SFRBM 2003 Oxidation of Macromolecules DNA, Lipid, Protein, Carbonhydrate, S101, Abstract No. 312.
Heinecke et al., Detecting Oxidative Modification of Biomeolecules with Isotope Dilution Mass Spectrometry: Sensitive and Quantitative Assays for Oxidized Amino Acids in Proteins and Tissues, Methods in Enzymology, vol. 300, pp. 124-144, year 1999.
Navab et al., The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL, Journal of Lipid Research, vol. 45, 2004, pp. 993-1007.
Panzenboeck et al., Effects of Reagent and Enzymatically Generated Hypochlorite on Physicochemical and Metabolic Properties of High Density Lipoproteins, vol. 272, No. 47, Nov. 21, 1997, pp. 29711-29720.
Pankhurst et al., Characterization of specially oxidized apolipoproteins in mildly oxidized high density lipoprotein, Journal of Lipid Research, vol. 44, 2003, pp. 349-355.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oxidized apoA-I determination by mass spectrometry does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxidized apoA-I determination by mass spectrometry, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidized apoA-I determination by mass spectrometry will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2657166

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.